GlaxoSmithKline Speeds up Batch Release Time: A Study in Digital Transformation
GlaxoSmithKline (GSK) wanted to review the structure of its batch production record and associated workflows as part of a continuous improvement process. Reducing batch review time usually results in faster batch cycle time, meaning higher throughput at the production facility and faster cash-to-cash cycle time. AspenTech was selected for this process due to integration with other solutions, such as Aspen InfoPlus.21® and GSK’s existing plant automation software (DCS). The pilot project was a resounding success, reducing order preparation time by 95% and record review time by over 50%.
Related Content
Overall equipment effectiveness (OEE) has proved to be helpful for continuous processes, but can the same principles be applied to improve equipment effectiveness in batch operations? The short answer is, yes. With some refocused metrics, manufacturers that run batch processes can shorten cycle times and address their own high-value problems by correlating performance, downtime and quality to products and equipment. We spoke with Stuart Forrest, MES Business Consultant for AspenTech, to get the inside scoop on batch OEE and find out what kind of results manufacturers can expect by tracking it through an advanced MES solution.